Company profile
LIVIUS PTE. LTD.
Reprogramming Aging Cells | miRNA & DNA Repair Platform for Longevity Therapeutics
- Industry
- Biotechnology Research
- Employees
- 7
- Headquarters
- Singapore
- Founded
- 2019
- Office locations
- 3
LIVIUS PTE. LTD. company summary
LIVIUS PTE. LTD. is a company in the Biotechnology Research industry, headquartered in Singapore, founded in 2019. On LinkedIn the company has around 7 employees. The company lists 3 office locations.
What technology does LIVIUS PTE. LTD. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About LIVIUS PTE. LTD.
LIVIUS Pte. Ltd. is a Singapore-based longevity biotechnology company advancing next-generation therapeutics by targeting cellular aging and genomic instability through cell reprogramming and DNA repair biology. Founded on more than 40 years of research led by our CSO, we have established a proprietary platform combining: - miRNA-guided cellular reprogramming - DNA damage response/repair pathway engagement observed during reprogramming (cell-based / preclinical studies) - Small-molecule approaches that upregulate endogenous miRNAs, supporting scalable and cost-effective development What we aim to solve Aging is driven by cellular senescence and accumulated genomic damage. We focus on upstream biology to enable root-cause interventions, rather than downstream symptom management. Core Technology - miRNA-based reprogramming designed to reset epigenetic markers associated with aging - Ongoing validation of DNA repair pathway activation in preclinical settings - Complementary small-molecule formats to support stability, manufacturability, and scale Pipeline Strategy LIVIUS operates a dual-track model: Therapeutics (core value driver): Lead programs in dermatology and ophthalmology are progressing through preclinical / IND-enabling work and IND preparation, alongside discovery programs spanning oncology and other age-related biology. Non-medical / Aesthetic applications (proof of concept & revenue): Science-driven skincare and hair/skin formulations, plus cell-quality enhancement additives. Vision Our mission is to extend healthspan, not just lifespan—by delivering interventions that help restore cellular function. Headquarters: Singapore Global presence: Japan, China, USA, UAE
Where is LIVIUS PTE. LTD. located?
LIVIUS PTE. LTD. lists 3 office locations.
Compare companies similar to LIVIUS PTE. LTD.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
LIVIUS PTE. LTD. livius.ltd | Biotechnology Research | 7 | 2019 | Singapore |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about LIVIUS PTE. LTD.
What does LIVIUS PTE. LTD. do?
LIVIUS Pte. Ltd. is a Singapore-based longevity biotechnology company advancing next-generation therapeutics by targeting cellular aging and genomic instability through cell reprogramming and DNA repair biology. Founded on more than 40 years of research led by our CSO, we have established a proprietary platform combining: - miRNA-guided cellular reprogramming - DNA damage response/repair pathway engagement observed during reprogramming (cell-based / preclinical studies) - Small-molecule approaches that upregulate endogenous miRNAs, supporting scalable and cost-effective development What we aim to solve Aging is driven by cellular senescence and accumulated genomic damage. We focus on upstream biology to enable root-cause interventions, rather than downstream symptom management. Core Technology - miRNA-based reprogramming designed to reset epigenetic markers associated with aging - Ongoing validation of DNA repair pathway activation in preclinical settings - Complementary small-molecule formats to support stability, manufacturability, and scale Pipeline Strategy LIVIUS operates a dual-track model: Therapeutics (core value driver): Lead programs in dermatology and ophthalmology are progressing through preclinical / IND-enabling work and IND preparation, alongside discovery programs spanning oncology and other age-related biology. Non-medical / Aesthetic applications (proof of concept & revenue): Science-driven skincare and hair/skin formulations, plus cell-quality enhancement additives. Vision Our mission is to extend healthspan, not just lifespan—by delivering interventions that help restore cellular function. Headquarters: Singapore Global presence: Japan, China, USA, UAE
How many employees does LIVIUS PTE. LTD. have?
LIVIUS PTE. LTD. has around 7 employees on LinkedIn.
Where is LIVIUS PTE. LTD. headquartered?
LIVIUS PTE. LTD. is headquartered in Singapore.
Where does LIVIUS PTE. LTD. have offices?
LIVIUS PTE. LTD. lists 3 office locations, including Singapore, 169662, SG; Office No.2525 25th Floor Iris Bay Tower Business, Dubai, AE; Shinjuku, Tokyo 160-0022, JP.
When was LIVIUS PTE. LTD. founded?
LIVIUS PTE. LTD. was founded in 2019.
Build a lead list from companies like LIVIUS PTE. LTD.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.